Siderosis - 40 Studies Found
Withdrawn |
: Treatment of Iron Overload Requiring Chelation Therapy :
|
Enrolling by invitation |
: A Case Control Study to Evaluate the Cognitive and Brain Function of β-thalassemia Patients. :
: 2013-08-07 |
Enrolling by invitation |
: PHOX2B Mutation-Confirmed Congenital Central Hypoventilation Syndrome in A Chinese Family: Presentations From Newborn to Adulthood : Central Alveolar Hypoventilation Syndrome : 2008-04-01 : Device: CPAP CPAP treatment for patients with congenital central hypoventilation syndrome |
Completed |
: Evaluation of the Safety, Tolerability, Pharmacokinetics (PK) and Effects on Liver Iron Concentration of ICL670 Relative to Deferoxamine(DFO). : Sickle Cell Disease : 2010-03-15 : Drug: ICL670 Daily doses of ICL670 were taken orally 30 minutes before breakfast. The doses range from 5 |
Completed |
: A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe Toxicity : Transfusional Iron Overload : 2010-01-05 : Drug: ICL670 |
Not yet recruiting |
: Efficacy of Bone Marrow Mesenchymal Stem Cell in Pulmonary Hemosiderosis : Idiopathic Pulmonary Hemosiderosis : 2016-12-03 : Biological: Bone marrow mesenchymal stem cells in treatment of Idiopathic pulmonary hemosiderosis |
Not yet recruiting |
: PHOX2B Mutation-Confirmed Congenital Central Hypoventilation Syndrome in A Chinese Family: Presentations From Newborn to Adulthood : Central Alveolar Hypoventilation Syndrome : 2008-04-01 : Device: CPAP CPAP treatment for patients with congenital central hypoventilation syndrome |
Active, not recruiting |
: Observational Study of Deferiprone (Ferriprox®) in the Treatment of Superficial Siderosis : Superficial Siderosis : 2011-01-20 |
Completed |
: A Prospective Safety Follow Up Study Of Subjects Enrolled In Study A4321001 And Who Have Received Drug Product : Siderosis : 2007-05-07 : Other: Observational Trial No intervention is being used in this study. |
Completed |
: An Epidemiological Study to Assess Iron Overload Using MRI in Patients With Transfusional Siderosis (TIMES Study) : Thalassemia, Non-transfusional-dependent Thalassemia (NTDT), Myeloplastic Dysplasia (MDS), Other Anemia : 2012-11-26 : Device: MRI scan MRI was used to measure both liver and cardiac iron loading (R2 by FerriScan and T2*, r |